Close
4

Seqens Seqens

X

Company profile for ImmunAbs

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
ImmunAbs has various antibody screening and engineering technologies such as phage display, single B cell cloning, and bispecific antibody development. Phage display is one of the main screening tools in this field. It is a method that displays various antibodies on bacteriophage surface and screens for high affinity antibodies from the bacteriophage library. Single B cell cloning involves isolation of antibody genes after scr...
ImmunAbs has various antibody screening and engineering technologies such as phage display, single B cell cloning, and bispecific antibody development. Phage display is one of the main screening tools in this field. It is a method that displays various antibodies on bacteriophage surface and screens for high affinity antibodies from the bacteriophage library. Single B cell cloning involves isolation of antibody genes after screening single B cells that express high affinity antibodies against a target antigen. Members of ImmunAbs have experience in screening antibodies and proceeding them to phase II clinical trials using such technologies.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
ImmunAbs
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
Gangnam-gu Second Floor, 427 Teheran-ro Seoul South Korea
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY